{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:38:07Z","timestamp":1786736287824,"version":"build-2736575974"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pharmacol"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/ijp.ijp_434_18","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T06:15:28Z","timestamp":1568268928000},"page":"276","source":"Crossref","is-referenced-by-count":7,"title":["Lurasidone-induced anemia: Is there a need for hematological monitoring?"],"prefix":"10.4103","volume":"51","author":[{"given":"AbhijeetD","family":"Faye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VivekC","family":"Kirpekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SudhirH","family":"Bhave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Tadke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil","family":"Gawande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0253-7613.266821-1","unstructured":"Sunovion Pharmaceuticals Inc. Latuda (lurasidone hydrochloride) Package Insert. Marlborough, Massachusetts: Sunovion Pharmaceuticals Inc.; 2013."},{"key":"key-10.4103\/0253-7613.266821-2","first-page":"21","article-title":"Lurasidone: A new treatment option for bipolar depression-a review","author":"Bawa","year":"2015","journal-title":"Innov Clin Neurosci"},{"key":"key-10.4103\/0253-7613.266821-3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/14740338.2017.1379989","article-title":"Lurasidone: Efficacy and safety in the treatment of psychotic and mood disorders","author":"Pompili","year":"2018","journal-title":"Expert Opin Drug Saf"},{"key":"key-10.4103\/0253-7613.266821-4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4103\/IJPSYM.IJPSYM_374_17","article-title":"Lurasidone induced thrombocytopenia: Is it a signal of drug induced myelosuppression?","author":"Rafi","year":"2018","journal-title":"Indian J Psychol Med","ISSN":"https:\/\/id.crossref.org\/issn\/0253-7176","issn-type":"print"},{"key":"key-10.4103\/0253-7613.266821-5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.9758\/cpn.2017.15.4.413","article-title":"Neutropenia with multiple antipsychotics including dose dependent neutropenia with lurasidone","author":"Sood","year":"2017","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"key-10.4103\/0253-7613.266821-6","first-page":"489","article-title":"Lurasidone HCl (Latuda), an oral, once-daily atypical antipsychotic agent for the treatment of patients with schizophrenia","author":"Cruz","year":"2011","journal-title":"P T"},{"key":"key-10.4103\/0253-7613.266821-7","unstructured":"Sunovion Pharmaceuticals. Latuda 18.5mg, 37mg and 74mg Film-Coated Tablets. Summary of Product Characteristics. Available from: http:\/\/www.medicines.org.uk\/emc\/medicine\/29125. [Last accessed on 2019 May 03]."},{"key":"key-10.4103\/0253-7613.266821-8","unstructured":"Greene EM, Hagemann TM. Drug-induced hematologic disorders. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey L, editors. Pharmacotherapy: A Pathophysiologic Approach. 10th ed.. New York: McGraw-Hill. Available from: http:\/\/accesspharmacy.mhmedical.com\/content.aspx?bookid=1861& sectionid=146079796. [Last accessed on 2019 May 03]."}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:39:57Z","timestamp":1786732797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.IJP_434_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"alternative-id":["266821"],"URL":"https:\/\/doi.org\/10.4103\/ijp.ijp_434_18","relation":{},"ISSN":["0253-7613"],"issn-type":[{"value":"0253-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}